Blueprint Medicines Corp
BPMC
Revenue
954.00k
▼-674.00k▼-41.40%
3 Months ChangeAssets
1.20B
▼-3.91M▼-0.3250%
3 Months ChangeLiabilities
886.50M
▲3.18M▲0.3602%
3 Months ChangeFree Cash Flow
-102.62M
▲22.93M▲18.26%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
Date | Revenue | Cost Of Revenue |
---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
Date | Net Profit/Loss |
---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
Date | Assets | Liabilities |
---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
Date | EPS | EPS (Diluted) |
---|---|---|
Outstanding Shares
Loading...
Date | Outstanding Shares |
---|---|
Recent 8-K/10-Q Filings
2024-10-30
Form 10-Q
ID: 0001558370-24-013960
2024-10-30
Form 8-K
ID: 0001558370-24-013882
2024-08-01
Form 10-Q
ID: 0001558370-24-010615
2024-08-01
Form 8-K
ID: 0001104659-24-084629
2024-06-14
Form 8-K
ID: 0001104659-24-071734
2024-05-24
Form 8-K
ID: 0001558370-24-008619
2024-05-02
Form 10-Q
ID: 0001558370-24-006563
2024-05-02
Form 8-K
ID: 0001558370-24-006451
2024-04-25
Form 8-K
ID: 0001104659-24-051658
2024-02-22
Form 8-K
ID: 0001104659-24-026343